155 related articles for article (PubMed ID: 12213789)
21. Dendritic cell-dependent inhibition of B cell proliferation requires CD22.
Santos L; Draves KE; Boton M; Grewal PK; Marth JD; Clark EA
J Immunol; 2008 Apr; 180(7):4561-9. PubMed ID: 18354178
[TBL] [Abstract][Full Text] [Related]
22. Transitional and marginal zone B cells have a high proportion of unmasked CD22: implications for BCR signaling.
Danzer CP; Collins BE; Blixt O; Paulson JC; Nitschke L
Int Immunol; 2003 Oct; 15(10):1137-47. PubMed ID: 13679384
[TBL] [Abstract][Full Text] [Related]
23. Immune regulation by the ST6Gal sialyltransferase.
Hennet T; Chui D; Paulson JC; Marth JD
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4504-9. PubMed ID: 9539767
[TBL] [Abstract][Full Text] [Related]
24. Natural ligands of the B cell adhesion molecule CD22 beta carry N-linked oligosaccharides with alpha-2,6-linked sialic acids that are required for recognition.
Powell LD; Sgroi D; Sjoberg ER; Stamenkovic I; Varki A
J Biol Chem; 1993 Apr; 268(10):7019-27. PubMed ID: 8463235
[TBL] [Abstract][Full Text] [Related]
25. Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily.
Kelm S; Pelz A; Schauer R; Filbin MT; Tang S; de Bellard ME; Schnaar RL; Mahoney JA; Hartnell A; Bradfield P
Curr Biol; 1994 Nov; 4(11):965-72. PubMed ID: 7533044
[TBL] [Abstract][Full Text] [Related]
26. Regulation of B cell development and B cell signalling by CD22 and its ligands alpha2,6-linked sialic acids.
Ghosh S; Bandulet C; Nitschke L
Int Immunol; 2006 Apr; 18(4):603-11. PubMed ID: 16497829
[TBL] [Abstract][Full Text] [Related]
27. Sialic acid binding domains of CD22 are required for negative regulation of B cell receptor signaling.
Jin L; McLean PA; Neel BG; Wortis HH
J Exp Med; 2002 May; 195(9):1199-205. PubMed ID: 11994425
[TBL] [Abstract][Full Text] [Related]
28. Antibody-targeted chemotherapy of B-cell lymphoma using calicheamicin conjugated to murine or humanized antibody against CD22.
DiJoseph JF; Popplewell A; Tickle S; Ladyman H; Lawson A; Kunz A; Khandke K; Armellino DC; Boghaert ER; Hamann P; Zinkewich-Peotti K; Stephens S; Weir N; Damle NK
Cancer Immunol Immunother; 2005 Jan; 54(1):11-24. PubMed ID: 15693135
[TBL] [Abstract][Full Text] [Related]
29. Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes.
Razi N; Varki A
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7469-74. PubMed ID: 9636173
[TBL] [Abstract][Full Text] [Related]
30. CD22 is a functional ligand for SH2 domain-containing protein-tyrosine phosphatase-1 in primary T cells.
Sathish JG; Walters J; Luo JC; Johnson KG; Leroy FG; Brennan P; Kim KP; Gygi SP; Neel BG; Matthews RJ
J Biol Chem; 2004 Nov; 279(46):47783-91. PubMed ID: 15364920
[TBL] [Abstract][Full Text] [Related]
31. Localization of the putative sialic acid-binding site on the immunoglobulin superfamily cell-surface molecule CD22.
van der Merwe PA; Crocker PR; Vinson M; Barclay AN; Schauer R; Kelm S
J Biol Chem; 1996 Apr; 271(16):9273-80. PubMed ID: 8621588
[TBL] [Abstract][Full Text] [Related]
32. The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils, and monocytes.
Engel P; Nojima Y; Rothstein D; Zhou LJ; Wilson GL; Kehrl JH; Tedder TF
J Immunol; 1993 Jun; 150(11):4719-32. PubMed ID: 7684411
[TBL] [Abstract][Full Text] [Related]
33. Difference in CD22 molecules in human B cells and basophils.
Toba K; Hanawa H; Fuse I; Sakaue M; Watanabe K; Uesugi Y; Higuchi W; Takahashi M; Aizawa Y
Exp Hematol; 2002 Mar; 30(3):205-11. PubMed ID: 11882357
[TBL] [Abstract][Full Text] [Related]
34. ST6Gal-I restrains CD22-dependent antigen receptor endocytosis and Shp-1 recruitment in normal and pathogenic immune signaling.
Grewal PK; Boton M; Ramirez K; Collins BE; Saito A; Green RS; Ohtsubo K; Chui D; Marth JD
Mol Cell Biol; 2006 Jul; 26(13):4970-81. PubMed ID: 16782884
[TBL] [Abstract][Full Text] [Related]
35. The amino-terminal immunoglobulin-like domain of sialoadhesin contains the sialic acid binding site. Comparison with CD22.
Nath D; van der Merwe PA; Kelm S; Bradfield P; Crocker PR
J Biol Chem; 1995 Nov; 270(44):26184-91. PubMed ID: 7592823
[TBL] [Abstract][Full Text] [Related]
36. The B-cell adhesion molecule CD22 is cross-species reactive and recognizes distinct sialoglycoproteins on different functional T-cell sub-populations.
Sgroi D; Stamenkovic I
Scand J Immunol; 1994 May; 39(5):433-8. PubMed ID: 8191218
[TBL] [Abstract][Full Text] [Related]
37. Cytokine-induced beta-galactoside alpha-2,6-sialyltransferase in human endothelial cells mediates alpha 2,6-sialylation of adhesion molecules and CD22 ligands.
Hanasaki K; Varki A; Stamenkovic I; Bevilacqua MP
J Biol Chem; 1994 Apr; 269(14):10637-43. PubMed ID: 8144653
[TBL] [Abstract][Full Text] [Related]
38. Ig domains 1 and 2 of murine CD22 constitute the ligand-binding domain and bind multiple sialylated ligands expressed on B and T cells.
Law CL; Aruffo A; Chandran KA; Doty RT; Clark EA
J Immunol; 1995 Oct; 155(7):3368-76. PubMed ID: 7561031
[TBL] [Abstract][Full Text] [Related]
39. CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling.
Tedder TF; Tuscano J; Sato S; Kehrl JH
Annu Rev Immunol; 1997; 15():481-504. PubMed ID: 9143697
[TBL] [Abstract][Full Text] [Related]
40. The B cell coreceptor CD22 associates with AP50, a clathrin-coated pit adapter protein, via tyrosine-dependent interaction.
John B; Herrin BR; Raman C; Wang YN; Bobbitt KR; Brody BA; Justement LB
J Immunol; 2003 Apr; 170(7):3534-43. PubMed ID: 12646615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
